Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort
about
Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndromeMouse DNA contamination in human tissue tested for XMRVA cautionary tale of virus and diseaseNo evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitroPCR and serology find no association between xenotropic murine leukemia virus-related virus (XMRV) and autismGut inflammation in chronic fatigue syndromeNo evidence of XMRV or related retroviruses in a London HIV-1-positive patient cohortInvestigation into the presence of and serological response to XMRV in CFS patientsLack of detection of XMRV in seminal plasma from HIV-1 infected men in The NetherlandsContamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequencesNew insights into the role of RNase L in innate immunityXenotropic murine leukemia virus-related virus in chronic fatigue syndrome and prostate cancerFailure to detect Xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndromeDisease-associated XMRV sequences are consistent with laboratory contaminationXenotropic murine leukemia virus-related gammaretrovirus in respiratory tractAbsence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United StatesSerologic and PCR testing of persons with chronic fatigue syndrome in the United States shows no association with xenotropic or polytropic murine leukemia virus-related virusesRETRACTED: Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donorsXenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditionsNo association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in JapanNo evidence for XMRV association in pediatric idiopathic diseases in FranceNo xenotropic murine leukemia virus-related virus detected in fibromyalgia patientsAn endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRVXenotropic murine leukemia virus-related virus (XMRV) in patients with systemic lupus erythematosusAbsence of XMRV retrovirus and other murine leukemia virus-related viruses in patients with chronic fatigue syndromeCharacterization, mapping, and distribution of the two XMRV parental provirusesPrevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in Dutch prostate cancer patientsXenotropic murine leukemia virus-related virus (XMRV) and blood transfusion: report of the AABB interorganizational XMRV task forceEvidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndromeVirology: Fighting for a causeXenotropic Murine Leukemia Virus-Related Virus (XMRV) and the Safety of the Blood Supply.Xenotropic MLV envelope proteins induce tumor cells to secrete factors that promote the formation of immature blood vessels.Fidelity of target site duplication and sequence preference during integration of xenotropic murine leukemia virus-related virus.Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRVXMRV and Public Health: The Retroviral Genome Is Not a Suitable Template for Diagnostic PCR, and Its Association with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Appears Unreliable.Lack of infection with XMRV or other MLV-related viruses in blood, post-mortem brains and paternal gametes of autistic individualsAntibody responses against xenotropic murine leukemia virus-related virus envelope in a murine model.Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.No association of xenotropic murine leukemia virus-related viruses with prostate cancer.DNA extraction columns contaminated with murine sequences.
P2860
Q21090022-AD6CD28B-7504-43C8-B33E-EE9E0D294EC6Q21093226-8C22F095-F69D-4880-BC3C-9F8AB3A0E02BQ21093240-FEF1DC4D-A121-4DC4-B4F9-B2D99DA5DD83Q21135591-9354DB61-5107-492C-89C3-A4AAD68383A4Q21198696-0660153C-17CC-4538-8233-39BF5D19D8DEQ21245060-9FE5A8A6-DDDA-49B0-A10C-D2F26EC7D8BAQ21560843-9A9A2707-E604-4973-B852-C76423DC656CQ21560846-D6ED163F-7D63-467B-9E28-CA46AC2D4B34Q21562183-37361BFB-C8E5-4D98-A34C-CAC814B5CBFCQ24595463-9B4A8650-F2DC-4DC1-A43A-9FFB0EB91E63Q24597466-8D0781E5-7C5D-4B7C-AA58-B4C054D8FCB2Q24600482-299676CC-E2D3-4339-9327-D6D148A6A6B0Q24600503-B434C427-E228-4ACC-A765-172CCACB09A0Q24602555-DBB9AC36-B5BE-4451-8FF8-825555FBD12EQ24603394-E1BE8F7C-C1C1-42AB-A579-66C09F05091FQ24604178-FD39ACAD-2B3D-489A-BDFB-122F6BA2AC5FQ24606213-1142D3BA-F6D3-48E5-B269-C507E96C3A52Q24613662-EE5D6798-9C00-4DDC-97FA-A9040A0AC51DQ24629910-11CB1293-095A-41C8-9ACB-7789B955611EQ24631125-9F514D63-628C-4E32-87B0-830132C46FFEQ24632862-775A2AC3-C69E-4E66-BD19-E8AE855AA73EQ24633092-F73D079D-6068-4B2D-B82B-67B243239E53Q24634544-7410B748-1CB1-44D7-A8D4-D98C1BF38184Q28236091-31677210-1320-4BE8-A0BE-92DFD76B37EBQ28236760-3FB03E11-AA38-485F-8BF4-D675E15F2360Q28251595-6AF012D9-57A2-4EB6-AC41-A0B5F213F86DQ28294334-03FF6B96-79CA-4603-AABC-E571A9FEDDF0Q28303254-2EBB469D-95FC-4E55-97C9-A9B196B7C41FQ28304673-E6C002BA-ACEC-42CF-A696-8EF32CE73A5EQ29301774-E2FB7EBD-ED32-42EE-A769-EFA00FD40304Q30249212-F96515CC-DD2E-4A3A-8FFA-8D6E590CF4DDQ30418789-FFE2157E-30DE-473D-A5D0-5F61DE7C6FBBQ33565359-53F07E16-0927-4C4A-8408-5E44A0581246Q33644321-5A15527F-3EEF-402B-A994-C88D5464ADF8Q33711512-28273821-466C-4963-9085-0582D06CE4EEQ33836739-BB9F3E25-F80C-44F4-9C67-E1B740477D04Q33873719-30ABD55C-B477-4BD0-8086-401A7A22EAE7Q33877299-B1D5B280-3B7C-496D-A80B-D6E84170D808Q33900919-1F7FAB05-D8D8-4134-ACD8-BE5E8D1AD5BDQ34005477-1A482455-867E-4375-869F-EE18B717EE34
P2860
Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prevalence of xenotropic murin ...... les from an established cohort
@ast
Prevalence of xenotropic murin ...... les from an established cohort
@en
Prevalence of xenotropic murin ...... les from an established cohort
@nl
type
label
Prevalence of xenotropic murin ...... les from an established cohort
@ast
Prevalence of xenotropic murin ...... les from an established cohort
@en
Prevalence of xenotropic murin ...... les from an established cohort
@nl
prefLabel
Prevalence of xenotropic murin ...... les from an established cohort
@ast
Prevalence of xenotropic murin ...... les from an established cohort
@en
Prevalence of xenotropic murin ...... les from an established cohort
@nl
P2093
P2860
P921
P356
P1433
P1476
Prevalence of xenotropic murin ...... les from an established cohort
@en
P2093
Arjan S de Jong
Caroline M A Swanink
Gerald W Verhaegh
Jochem M D Galama
Jos W M van der Meer
Kjerstin H Lanke
Mihai G Netea
Willem J G Melchers
P2860
P356
10.1136/BMJ.C1018
P407
P433
P577
2010-01-01T00:00:00Z